Highlights and Quick Summary
- Average Common Equity for the quarter ending February 28, 2022 was $308 Million (a -0.45% decrease compared to previous quarter)
- Year-over-year quarterly Average Common Equity decreased by -4.44%
- Annual Average Common Equity for 2021 was $305 Million (a 28.43% increase from previous year)
- Annual Average Common Equity for 2020 was $237 Million (a 22.34% increase from previous year)
- Annual Average Common Equity for 2019 was $194 Million (a 87.04% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Average Common Equity of Organigram Holdings Inc.
Most recent Average Common Equityof OGI including historical data for past 10 years.Interactive Chart of Average Common Equity of Organigram Holdings Inc.
Organigram Holdings Inc. Average Common Equity for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $308.16 | – | – | – | – |
| 2021 | $309.56 | $301.81 | $322.48 | $249.55 | $304.72 |
| 2020 | $245.37 | $234.74 | $240.02 | $247.41 | $237.26 |
| 2019 | $213.4 | $195.61 | $240.02 | $247.41 | $193.93 |
| 2018 | – | – | $213.4 | $195.61 | $103.69 |
| 2017 | – | – | – | – | $49.58 |
| 2016 | – | – | – | – | $49.58 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic